Trials / Unknown
UnknownNCT03470688
Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents
An Observational Study Designed to Investigate the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents in Australian Rheumatology
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Opal Rheumatology Ltd. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An observational study investigating the utilisation and effectiveness of originator and biosimilar anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Originator | Originator anti-TNF agents |
| BIOLOGICAL | Biosimilar | Biosimilar anti-TNF agents |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2021-06-01
- Completion
- 2021-12-31
- First posted
- 2018-03-20
- Last updated
- 2018-03-21
Locations
22 sites across 1 country: Australia
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03470688. Inclusion in this directory is not an endorsement.